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A new plug-based MANTATM (Teleflex Inc., Morrisville, NC) vascular closure device was 
recently introduced. Although prospective studies of MANTA have reported promising 
results of 2% to 4% of major vascular complication (VC) in selected patients who underwent 
transfemoral-transcatheter aortic valve replacement (TF-TAVR) (1), major VC ranges up to 
9% using MANTA in unselected patients deemed to have calcified common femoral arteries 
(CFA) (2,3). Therefore, we recently developed an ultrasound-navigated method of MANTA 
deployment (US-MANTA) with the aim of exploring optimal usage and understanding failure 
mechanisms. We sought to assess the efficacy of the US-MANTA to compare the incidence 
of access-site major VC and bleeding between the periods before and after introduction of 
US-MANTA technique in the real-world setting.  
Vascular access was established under ultrasound-navigated puncture avoiding 
anterior wall calcification and bifurcation of CFA in all cases. At the end of procedures, the 
activated clotting time was controlled to be below 250 seconds by protamine administration. 
Detailed descriptions of US-MANTA method are as follows: a scanning in a longitudinal 
view was used to identify the CFA with the MANTA toggle in situ (Figure 1A and B).  
Step 1: An ultrasound-image was maintained, and the sheath was withdrawn up to 
pre-determined depth+1cm. The toggle was released at this level and confirmed located 
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adequately in the vessel as shown in Figure 1C. If pre-determined deployment depth was not 
considered reliable, a new deployment depth was visually determined by confirming the 
toggle locating inside the vessel. 
Step 2: The assembly was pulled back slowly under maintaining an ultrasound-image 
centered on the toggle with 45 degrees or more between skin surface and MANTA sheath. It 
was confirmed that the toggle was attached vessel wall in parallel (Figure 1D). If toggle stack 
due to posterior vessel wall calcification occurred, MANTA was pushed forward and released 
from calcification. Then, the assembly was pulled back again with rotating device by 30 to 45 
degrees avoiding stack. 
Step 3: Pulling force was maintained under monitoring by the color code of the 
tension gauge (green code) until the collagen pad getting close to the vessel wall. Then, the 
blue tamper tube was advanced to further compact the collagen pad with keeping pulling 
force (Figure 1E). 
Step 4: Hemostasis was confirmed in visual and ultrasound scan. According to the 
situation, manual compression with gentle pressure was added. 
In a retrospective, single-center study performed between September 2017 and May 
2019, 246 consecutive patients with conventional MANTA deployment (C-MANTA) (1) and 
 3
153 consecutive patients with US-MANTA were evaluated. One to one propensity score 
matching resulted in 135 pairs with adequate balance of baseline characteristics with 
comparable sheath to femoral artery ratio (C-MANTA:1.03±0.26 vs. US-MANTA:1.04±0.21, 
P=0.36) and moderate to severe calcification of CFA (C-MANTA:25.2% vs. US-
MANTA:20.0%, P=0.38).  
 In matched series, access-site major VCs occurred significantly less frequently in 
patients with US-MANTA in comparison to those with C-MANTA (1.5% vs. 7.4%, P=0.030), 
with significantly lower incidence of access-site life-threatening or major bleeding 
complication (1.5% vs. 8.9%, P=0.008). Moreover, significantly fewer incidence of minor 
VCs (2.2% vs. 8.2%, P=0.028) was observed in patients with US-MANTA. In multivariate 
analysis, US-MANTA (Odds ratio: 0.29, 95% confidence interval: 0.08 to 0.80) was 
identified as an only independent predictor of less frequent access-site major VCs. Potential 
mechanisms of MANTA failure are also reported by surgical inspection and/or ultrasound 
imaging at the time of VCs in total study cohort (Figure 1F).  
 US-MANTA may enable more accurate hemostasis following TF-TAVR requiring a 
large-bore arteriotomy in unselected patients as compared with C-MANTA. Of note, this 
study is a single-center retrospective study and large prospective trials are warranted to 
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further investigate the efficacy of US-MANTA strategy in the real-world setting. 
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FIGURE LEGEND 
Figure 1. Ultrasound-navigated MANTA method and potential failure mechanisms 
(A) A scanning in a longitudinal view is used to identify the common femoral artery with the 
MANTA. (B) Scheme of a longitudinal view (asterisk: toggle, arrow: vessel wall). (C) The 
toggle locating within a longitudinal view. (D) The toggle attaching vessel in parallel. (E) 
Arteriotomy sandwiched by the toggle and collagen pad (arrow head). 
(F) Schema of MANTA deployment failure. Type 0: appropriate MANTA deployment under 
ultrasound. All cases with type 1,2 and 4 failure required unplanned surgical repairs. Cases 
with type 3 and 5 failure were associated with late pseudoaneurysm. In part of these cases, 
unplanned surgical or endovascular repairs were performed. 
 

